跳至主要内容
临床试验/ACTRN12605000440628
ACTRN12605000440628已完成不适用

A randomised controlled trial to evaluate the efficacy of a mindfulness-based cognitive behavioural therapy in reducing distress and compliance in medication-resistant command hallucinations in psychotic disorders.

The Mental Health Research Institute of Victoria0 个研究点目标入组 43 人开始时间: 2005年9月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
43

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • Current diagnosis of schizophrenia, schizoaffective disorder, psychosis not otherwise specified or mood disorder with psychotic features; have experienced command hallucinations over previous 6 months that have cause distress or dysfuntion despite receiving treatment with anti-psychotic medication at doses in therapeutic range.

排除标准

  • Neurological disorder affecting cognitive function; premorbid IQ below 70; insufficient conversational English for meaningful participation.

研究者

发起方
The Mental Health Research Institute of Victoria

相似试验

Treatment of Resistant Command Hallucinations | 临床试验